Skip to main content
Top
Published in: Rheumatology International 10/2011

01-10-2011 | Review

Coexistence of vasculitides with Familial Mediterranean Fever

Authors: Kenan Aksu, Gokhan Keser

Published in: Rheumatology International | Issue 10/2011

Login to get access

Abstract

Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent self-limited attacks of fever accompanied with peritonitis, pleuritis, or arthritis. FMF may coexist with various systemic inflammatory diseases including vasculitides, spondyloarthritis, multiple sclerosis, and inflammatory bowel disease. Among these coexistences, this review concentrates on vasculitic disorders, with the aim of increasing the awareness of FMF-vasculitis association. This association does not merely show a coincidentally increased frequency of vasculitic disorders in FMF; rather, it seems that FMF patients might be at increased risk of developing vasculitis. Indeed, as also suggested by some authors, vasculitis might be an essential feature of FMF. Among the vasculitic disorders reported to be associated with FMF, Henoch–Schönlein purpura, and classical polyarteritis nodosa come the first, possibly followed up by protracted febrile myalgia. There is also an ongoing debate whether Behçet’s disease (BD) more frequently seen in FMF than expected by chance alone. In this review, the associations of various vasculitic disorders with FMF and the possible pathogenic mechanisms underlying these associations, as well as the frequencies and clinical significances of FMF-related MEFV mutations in various vasculitides including BD, are discussed in the context of the available data.
Literature
1.
go back to reference Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 28(351):659–664CrossRef Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 28(351):659–664CrossRef
3.
go back to reference Ben-Chetrit E, Touitou I (2009) Familial Mediterranean Fever in the world. Arthritis Rheum 61:1447–1453PubMedCrossRef Ben-Chetrit E, Touitou I (2009) Familial Mediterranean Fever in the world. Arthritis Rheum 61:1447–1453PubMedCrossRef
4.
go back to reference French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef
5.
go back to reference Aksentijevich I, Torosyan Y, Samuels J et al (1999) Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 64:949–962PubMedCrossRef Aksentijevich I, Torosyan Y, Samuels J et al (1999) Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 64:949–962PubMedCrossRef
6.
go back to reference Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed
7.
go back to reference Ozdogan H, Arisoy N, Kasapcopur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed Ozdogan H, Arisoy N, Kasapcopur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed
8.
go back to reference Hatemi G, Masatlioglu S, Gogus F, Ozdogan H (2004) Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 117:516–519PubMedCrossRef Hatemi G, Masatlioglu S, Gogus F, Ozdogan H (2004) Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 117:516–519PubMedCrossRef
9.
go back to reference Flatau E, Kohn D, Schiller D, Lurie M, Levy E (1982) Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum 25:42–47PubMedCrossRef Flatau E, Kohn D, Schiller D, Lurie M, Levy E (1982) Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum 25:42–47PubMedCrossRef
10.
go back to reference Schlesinger M, Rubinow A, Vardy PA (1985) Henoch-Schönlein purpura and familial Mediterranean fever. Isr J Med Sci 21:83–85PubMed Schlesinger M, Rubinow A, Vardy PA (1985) Henoch-Schönlein purpura and familial Mediterranean fever. Isr J Med Sci 21:83–85PubMed
11.
go back to reference Sachs D, Langevitz P, Morag B, Pras M (1987) Polyarteritis nodosa and familial Mediterranean fever. Br J Rheumatol 26:139–141PubMedCrossRef Sachs D, Langevitz P, Morag B, Pras M (1987) Polyarteritis nodosa and familial Mediterranean fever. Br J Rheumatol 26:139–141PubMedCrossRef
12.
go back to reference Glikson M, Galun E, Schlesinger M et al (1989) Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 16:536–539PubMed Glikson M, Galun E, Schlesinger M et al (1989) Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 16:536–539PubMed
13.
go back to reference Tunca M, Akar S, Onen F, Turkish FMF Study Group et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef Tunca M, Akar S, Onen F, Turkish FMF Study Group et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef
14.
go back to reference Ozcakar ZB, Yalcinkaya F, Cakar N et al (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef Ozcakar ZB, Yalcinkaya F, Cakar N et al (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef
15.
go back to reference Yalcinkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef Yalcinkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef
16.
go back to reference Langevitz P, Zemer D, Livneh A et al (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed Langevitz P, Zemer D, Livneh A et al (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMed
17.
go back to reference Schwartz T, Langevitz P, Zemer D et al (2000) Behçet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRef Schwartz T, Langevitz P, Zemer D et al (2000) Behçet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295PubMedCrossRef
18.
go back to reference Birlik M, Tunca M, Hizli N et al (1998) Coexistence of familial Mediterranean fever with sacroiliitis and Behçet’s disease: a rare occurrence. Clin Rheumatol 17:397–399PubMedCrossRef Birlik M, Tunca M, Hizli N et al (1998) Coexistence of familial Mediterranean fever with sacroiliitis and Behçet’s disease: a rare occurrence. Clin Rheumatol 17:397–399PubMedCrossRef
19.
go back to reference Ben-Chetrit E, Yazici H (2002) Thoughts on the proposed links between Behçet’s disease and familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S1–S2PubMed Ben-Chetrit E, Yazici H (2002) Thoughts on the proposed links between Behçet’s disease and familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S1–S2PubMed
20.
go back to reference Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21(4 Suppl 30):S35–S37PubMed Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21(4 Suppl 30):S35–S37PubMed
21.
go back to reference Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet’s disease. Scand J Rheumatol 37:370–374PubMedCrossRef Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet’s disease. Scand J Rheumatol 37:370–374PubMedCrossRef
22.
go back to reference Padeh S, Shinar Y, Pras E et al (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 30:185–190PubMed Padeh S, Shinar Y, Pras E et al (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 30:185–190PubMed
23.
go back to reference Ureten K, Gönülalan G, Akbal E et al (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915PubMedCrossRef Ureten K, Gönülalan G, Akbal E et al (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915PubMedCrossRef
24.
go back to reference Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81PubMedCrossRef Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81PubMedCrossRef
25.
go back to reference Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nature Review Rheum 7:105–112CrossRef Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nature Review Rheum 7:105–112CrossRef
26.
go back to reference Lachmann HJ, Sengul B, Yavuzsen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef Lachmann HJ, Sengul B, Yavuzsen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRef
27.
go back to reference Cattan D (2005) MEFV mutation carriers and diseases other than familial mediterranean fever: proved and non-proved associations; putative biological advantage. Current Drug Targets Inflamm Allergy 4:105–112CrossRef Cattan D (2005) MEFV mutation carriers and diseases other than familial mediterranean fever: proved and non-proved associations; putative biological advantage. Current Drug Targets Inflamm Allergy 4:105–112CrossRef
28.
go back to reference Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117PubMedCrossRef Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117PubMedCrossRef
29.
go back to reference Yang X-F, Yin Y, Wang H (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg 5:125–142PubMedCrossRef Yang X-F, Yin Y, Wang H (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg 5:125–142PubMedCrossRef
30.
go back to reference Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550PubMedCrossRef Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550PubMedCrossRef
31.
go back to reference Dinarello CA (2009) Interleukin-1β and the autoinflammatory diseases. N Engl J Med 360(23):2467–2470PubMedCrossRef Dinarello CA (2009) Interleukin-1β and the autoinflammatory diseases. N Engl J Med 360(23):2467–2470PubMedCrossRef
32.
go back to reference Rafiq S, Stevens K, Hurst AJ et al (2007) Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8:344–351PubMedCrossRef Rafiq S, Stevens K, Hurst AJ et al (2007) Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8:344–351PubMedCrossRef
33.
go back to reference Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831PubMedCrossRef Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831PubMedCrossRef
34.
go back to reference Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10:148–155PubMedCrossRef Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10:148–155PubMedCrossRef
35.
go back to reference Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20:3–9PubMedCrossRef Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20:3–9PubMedCrossRef
36.
go back to reference Aypar E, Ozen S, Okur H et al (2003) Th1 polarization in familial mediterranean fever. J Rheumatol 30:2011–2013PubMed Aypar E, Ozen S, Okur H et al (2003) Th1 polarization in familial mediterranean fever. J Rheumatol 30:2011–2013PubMed
37.
go back to reference Simsek I, Pay S, Pekel A et al (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef Simsek I, Pay S, Pekel A et al (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef
38.
go back to reference Manukyan G, Ghazaryan K, Ktsoyan Z et al (2010) Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50:146–151PubMedCrossRef Manukyan G, Ghazaryan K, Ktsoyan Z et al (2010) Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50:146–151PubMedCrossRef
39.
go back to reference Grau GE, Roux-Lombard P, Gysler C et al (1989) Serum cytokine changes in systemic vasculitis. Immunology 68:196–198PubMed Grau GE, Roux-Lombard P, Gysler C et al (1989) Serum cytokine changes in systemic vasculitis. Immunology 68:196–198PubMed
40.
go back to reference Saadoun D, Bieche I, Authier FJ et al (2007) Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56:1315–1324PubMedCrossRef Saadoun D, Bieche I, Authier FJ et al (2007) Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56:1315–1324PubMedCrossRef
41.
go back to reference Freire Ade L, Bertolo MB, de Pinho AJ Jr et al (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease. Clin Rheumatol 23:203–205PubMedCrossRef Freire Ade L, Bertolo MB, de Pinho AJ Jr et al (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease. Clin Rheumatol 23:203–205PubMedCrossRef
42.
go back to reference Del Vecchio GC, Penza R, Altomare M et al (2008) Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 30:623–629PubMedCrossRef Del Vecchio GC, Penza R, Altomare M et al (2008) Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 30:623–629PubMedCrossRef
43.
go back to reference Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803–815PubMedCrossRef Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803–815PubMedCrossRef
44.
go back to reference Akdogan A, Calguneri M, Yavuz B et al (2006) Are Familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef Akdogan A, Calguneri M, Yavuz B et al (2006) Are Familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef
45.
go back to reference Terekeci HM, Oktenli C, Ozgurtas T et al (2008) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35:2024–2029PubMed Terekeci HM, Oktenli C, Ozgurtas T et al (2008) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35:2024–2029PubMed
46.
go back to reference Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437–449PubMedCrossRef Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437–449PubMedCrossRef
47.
go back to reference Aksu G, Ozturk C, Kavakli K et al (2007) Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 26:366–370PubMedCrossRef Aksu G, Ozturk C, Kavakli K et al (2007) Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 26:366–370PubMedCrossRef
48.
go back to reference Demirel A, Celkan T, Kasapcopur O et al (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr 167:279–285PubMedCrossRef Demirel A, Celkan T, Kasapcopur O et al (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr 167:279–285PubMedCrossRef
49.
go back to reference Aoun EG, Musallam KM, Uthman I et al (2009) Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors. Lupus 18:845–847PubMedCrossRef Aoun EG, Musallam KM, Uthman I et al (2009) Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors. Lupus 18:845–847PubMedCrossRef
50.
go back to reference Sari S, Egritas O, Bukulmez A et al (2009) Is familial mediterranean fever a possible cofactor for budd-chiari syndrome? J Pediatr Gastroenterol Nutr 49:481–484PubMedCrossRef Sari S, Egritas O, Bukulmez A et al (2009) Is familial mediterranean fever a possible cofactor for budd-chiari syndrome? J Pediatr Gastroenterol Nutr 49:481–484PubMedCrossRef
51.
go back to reference Ozel Demiralp DF, Ekim M, Akar N (2009) The effect of plasminogen activator inhibitor-1–675 4G/5G polymorphism on Familial Mediterranean Fever (FMF) Disease. Clin Appl Thromb Hemost 15:443–447PubMedCrossRef Ozel Demiralp DF, Ekim M, Akar N (2009) The effect of plasminogen activator inhibitor-1–675 4G/5G polymorphism on Familial Mediterranean Fever (FMF) Disease. Clin Appl Thromb Hemost 15:443–447PubMedCrossRef
52.
go back to reference Serrano R, Martínez MA, Andrés A et al (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167PubMedCrossRef Serrano R, Martínez MA, Andrés A et al (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167PubMedCrossRef
53.
go back to reference Cocco G (2008) Vasculitis, left bundle branch block, and Raynaud’s phenomenon as a manifestation of familial Mediterranean fever. Arch Med Sci 4:460–464 Cocco G (2008) Vasculitis, left bundle branch block, and Raynaud’s phenomenon as a manifestation of familial Mediterranean fever. Arch Med Sci 4:460–464
54.
go back to reference Efthimiou P, Flavell RA, Furlan A et al (2008) Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 26(1 Suppl 48):S53–S61PubMed Efthimiou P, Flavell RA, Furlan A et al (2008) Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 26(1 Suppl 48):S53–S61PubMed
55.
go back to reference Tekin M, Yalcinkaya F, Tumer N (1999) Familial mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol 18:446–449PubMedCrossRef Tekin M, Yalcinkaya F, Tumer N (1999) Familial mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol 18:446–449PubMedCrossRef
56.
go back to reference Yalcinkaya F, Ince E, Ucar T et al (2002) Antistreptococcal response is exaggerated in children with familial Mediterranean fever. Clin Rheumatol 21:378–381PubMedCrossRef Yalcinkaya F, Ince E, Ucar T et al (2002) Antistreptococcal response is exaggerated in children with familial Mediterranean fever. Clin Rheumatol 21:378–381PubMedCrossRef
57.
go back to reference David J, Ansell BM, Woo P (1993) Polyarteritis nodosa associated with streptococcus. Arch Dis Child 69:685–688PubMedCrossRef David J, Ansell BM, Woo P (1993) Polyarteritis nodosa associated with streptococcus. Arch Dis Child 69:685–688PubMedCrossRef
58.
go back to reference Cimolai N, Macnab A (1991) Schonlein-Henoch purpura and Streptococcus equisimilis. Br J Dermatol 125:403PubMedCrossRef Cimolai N, Macnab A (1991) Schonlein-Henoch purpura and Streptococcus equisimilis. Br J Dermatol 125:403PubMedCrossRef
59.
go back to reference Masuda M, Nakanishi K, Yoshizawa N et al (2003) Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 41:366–370PubMedCrossRef Masuda M, Nakanishi K, Yoshizawa N et al (2003) Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 41:366–370PubMedCrossRef
60.
go back to reference Soylu A, Kasap B, Türkmen M et al (2006) Febrile myalgia syndrome in familial Mediterranean fever. J Clin Rheumatol 12:93–96PubMedCrossRef Soylu A, Kasap B, Türkmen M et al (2006) Febrile myalgia syndrome in familial Mediterranean fever. J Clin Rheumatol 12:93–96PubMedCrossRef
61.
go back to reference Candan F, Ayan S, Tas F et al (2005) Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int 25:475–477PubMedCrossRef Candan F, Ayan S, Tas F et al (2005) Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int 25:475–477PubMedCrossRef
63.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C (2002) Henoch-Schönlein Purpura. In: Ball GV, Bridges SL (eds) Vasculitis. Oxford University Press, New York, pp 476–494 Gonzalez-Gay MA, Garcia-Porrua C (2002) Henoch-Schönlein Purpura. In: Ball GV, Bridges SL (eds) Vasculitis. Oxford University Press, New York, pp 476–494
65.
go back to reference Tekin M, Yalcinkaya F, Tumer N et al (2000) Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef Tekin M, Yalcinkaya F, Tumer N et al (2000) Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis. Acta Paediatr 89:177–182PubMedCrossRef
66.
go back to reference Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661PubMedCrossRef Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 143:658–661PubMedCrossRef
67.
go back to reference Colmegna I, Maldonado-Cocco JA (2005) Polyarteritis nodosa revisited. Curr Rheumatol Rep 7:288–296PubMedCrossRef Colmegna I, Maldonado-Cocco JA (2005) Polyarteritis nodosa revisited. Curr Rheumatol Rep 7:288–296PubMedCrossRef
68.
go back to reference Levine SM, Hellmann DB, Stone JH (2002) Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med 112:386–391PubMedCrossRef Levine SM, Hellmann DB, Stone JH (2002) Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med 112:386–391PubMedCrossRef
69.
go back to reference Michet CJ (1990) Polymyalgia rheumatica/giant cell arteritis and other vasculitides. Rheum Dis Clin North Am 16:667–680PubMed Michet CJ (1990) Polymyalgia rheumatica/giant cell arteritis and other vasculitides. Rheum Dis Clin North Am 16:667–680PubMed
70.
go back to reference Ozen S, Ben-Chetrit E, Bakkaloglu A et al (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287PubMedCrossRef Ozen S, Ben-Chetrit E, Bakkaloglu A et al (2001) Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281–287PubMedCrossRef
71.
go back to reference Akar S, Goktay Y, Akinci B et al (2005) A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations. Rheumatol Int 25:60–64PubMedCrossRef Akar S, Goktay Y, Akinci B et al (2005) A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations. Rheumatol Int 25:60–64PubMedCrossRef
72.
go back to reference Bircan Z, Usluer H (2008) Protracted febrile myalgia mimicking polyarteritis nodosa. J Clin Rheumatol 14:222–225PubMed Bircan Z, Usluer H (2008) Protracted febrile myalgia mimicking polyarteritis nodosa. J Clin Rheumatol 14:222–225PubMed
73.
go back to reference Tufan G, Demir S (2010) Uncommon clinical pattern of FMF: protracted febrile myalgia syndrome. Rheumatol Int 30:1089–1090PubMedCrossRef Tufan G, Demir S (2010) Uncommon clinical pattern of FMF: protracted febrile myalgia syndrome. Rheumatol Int 30:1089–1090PubMedCrossRef
74.
go back to reference Sidi G, Shinar Y, Livneh A et al (2000) Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 29:174–176PubMedCrossRef Sidi G, Shinar Y, Livneh A et al (2000) Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 29:174–176PubMedCrossRef
75.
76.
go back to reference La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 23(4):71–77 La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 23(4):71–77
77.
go back to reference Schwartz T, Langevitz P, Zemer D et al (1997) Increased incidence of Behcet’s disease (BD) in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M (eds) Familial mediterranean fever. Freund Publishing House, Tel-Aviv, pp 148–150 Schwartz T, Langevitz P, Zemer D et al (1997) Increased incidence of Behcet’s disease (BD) in familial Mediterranean fever (FMF). In: Sohar E, Gafni J, Pras M (eds) Familial mediterranean fever. Freund Publishing House, Tel-Aviv, pp 148–150
78.
go back to reference Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822PubMed Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822PubMed
79.
go back to reference Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behçet’s disease-are they associated? J Rheumatol 29:530–534PubMed Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behçet’s disease-are they associated? J Rheumatol 29:530–534PubMed
80.
go back to reference Esen F, Celik A, Yazici H (2009) The use of diseased control groups in genetic association studies. Clin Exp Rheumatol 27(2 Suppl 53):S4–S5PubMed Esen F, Celik A, Yazici H (2009) The use of diseased control groups in genetic association studies. Clin Exp Rheumatol 27(2 Suppl 53):S4–S5PubMed
81.
go back to reference Livneh A, Aksentijevich I, Langevitz P et al (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRef Livneh A, Aksentijevich I, Langevitz P et al (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 9:191–196PubMedCrossRef
82.
go back to reference Touitou I, Magne X, Molinari N et al (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRef Touitou I, Magne X, Molinari N et al (2000) MEFV mutations in Behçet’s disease. Hum Mutat 16:271–272PubMedCrossRef
83.
go back to reference Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behçet’s disease. Scand J Rheumatol 34:56–58PubMedCrossRef Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behçet’s disease. Scand J Rheumatol 34:56–58PubMedCrossRef
84.
go back to reference Rabinovich E, Shinar Y, Leiba M et al (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRef Rabinovich E, Shinar Y, Leiba M et al (2007) Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48–52PubMedCrossRef
85.
go back to reference Dursun A, Durakbasi-Dursun HG, Zamani AG et al (2006) Genetic analysis of MEFV gene pyrin domain in patients with Behçet’s disease. Mediators Inflamm 41783(3):1–4CrossRef Dursun A, Durakbasi-Dursun HG, Zamani AG et al (2006) Genetic analysis of MEFV gene pyrin domain in patients with Behçet’s disease. Mediators Inflamm 41783(3):1–4CrossRef
86.
go back to reference Espinosa G, Arostegui JI, Plaza S et al (2005) Behçet’s disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 23(4 Suppl 38):S64–S66PubMed Espinosa G, Arostegui JI, Plaza S et al (2005) Behçet’s disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 23(4 Suppl 38):S64–S66PubMed
87.
go back to reference Schlesinger M, Kopolovic J, Viskoper RJ, Ron N (1983) A case of familial Mediterranean fever with cutaneous vasculitis and immune complex nephritis: light, electron, and immunofluorescent study of renal biopsy. Am J Clin Pathol 80:511–514PubMed Schlesinger M, Kopolovic J, Viskoper RJ, Ron N (1983) A case of familial Mediterranean fever with cutaneous vasculitis and immune complex nephritis: light, electron, and immunofluorescent study of renal biopsy. Am J Clin Pathol 80:511–514PubMed
88.
go back to reference Barzilai A, Langevitz P, Goldberg I et al (2000) Erysipelas-like erythema of familial mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef Barzilai A, Langevitz P, Goldberg I et al (2000) Erysipelas-like erythema of familial mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 42:791–795PubMedCrossRef
Metadata
Title
Coexistence of vasculitides with Familial Mediterranean Fever
Authors
Kenan Aksu
Gokhan Keser
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1840-z

Other articles of this Issue 10/2011

Rheumatology International 10/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.